Kyle Misewich, Vancouver

About Kyle

Kyle practises corporate and securities law, including public and private company financings, mergers and acquisitions, take-over bids and corporate reorganizations. He also advises clients in connection with securities law compliance, disclosure obligations, stock exchange matters, corporate governance and general corporate law.

Expand all

Select Experience

Recent representative transactions include assisting:

M&A and Reorganizations

NervGen in connection with its C$23-million public offering of units
enGene in connection with its US$138-million de-SPAC merger with Forbion European Acquisition
Neovasc in connection with its acquisition by Shockwave for approximately US$100-million
NioCorp Developments Ltd. on its business combination with GX Acquisition Corp. II, a US special purpose acquisition corporation (SPAC), and concurrent financings valued at up to US$71.9-million
Trilogy International Partners in connection with the sale of its subsidiary, Two Degrees, for NZ$1.315-billion
Trillium Therapeutics Inc. in connection with its acquisition by Pfizer for US$2.22-billion
Absolute Software Corporation in connection with its US$340-million acquisition of NetMotion Software, Inc.
CRH Medical Corporation in connection with its acquisition by Well Health Technologies Corp. in a deal valued at US$372.9-million
Novoheart Holdings Inc. in a going private transaction valued at approximately C$100-million
Atico Mining Corporation in connection with its acquisition of Toachi Mining Inc.
Washington Companies in connection with its C$1.5-billion acquisition of Dominion Diamond Corporation
Trilogy International Partners on a US$875-million business combination with Alignvest Acquisition Corporation, a special purpose acquisition corporation (SPAC)
Neovasc in connection with the sale of its tissue business and concurrent private placement to Boston Scientific for US$75-million
Reservoir Minerals Inc. on its private placement, credit agreement and plan of arrangement with Nevsun Resources Ltd. for a total of US$575-million
Capstone Mining in connection with its acquisition of the Pinto Valley Mine from BHP Billiton for US$650-million
Lithium One Inc. in connection with its acquisition by Galaxy Resources for C$112-million in exchangeable shares

Corporate Finance

The underwriters in separate public offerings of CubicFarm Systems Corp. for gross proceeds of C$20-million, C$25.3-million, C$16.2-million and C$2.8-million
The underwriters in connection with a US$20-million public offering of units by Medicenna Therapeutics
NervGen Pharma in connection with its US$15.23-million private placement of units
ESSA Pharma Inc. in connection with its US$130-million underwritten public offering of common shares
Kadestone Capital Corp. on its formation and initial public offering
The underwriters in a C$23-million bought deal public offering of units of Rubicon Organics Inc.
Neovasc in connection with its US$72-million MJDS registered direct offering of common shares
Svante Technologies Inc. in connection with its US$16-million Series C preferred share financing, US$100-million Series D preferred share financing and US$318-million Series E preferred share financing
ESSA Pharma in connection with its US$26-million prospectus offering and concurrent private placement of common shares and pre-funded warrants
Neovasc in connection with its US$37.5-million underwritten offering of Series A and Series B units (comprised of a combination of common shares or Series D pre-funded warrants, Series C units and Series A, B, C and F warrants to purchase common shares) and concurrent US$27.8-million private placement of notes and Series E warrants to purchase common shares
The underwriters of B2Gold Corp. on its at-the-market offering of up to US$100-million
The underwriters on a private placement of flow-through common shares of Sabina Gold & Silver Corp. for gross proceeds of approximately C$34.5-million
Esperanza Resources Corp. on a private placement of special warrants for gross proceeds of approximately C$34-million
NovaGold Resources Inc. on a public offering of common shares for gross proceeds of approximately US$332.5-million